Previous Close | 4.35 |
1-Year Change | -33.59% |
6-Months Change | 31.42% |
3-Months Change | 29.85% |
Moving Avg (50d) | 3.6073 |
Moving Avg (200d) | 8.5473 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 273.0M |
Beta (3-Years) | 1.43 |
Revenue Growth (ttm) | 16.68% |
Net Profit Margin (ttm) | -69.07% |
Return On Assets (ttm) | -36.91% |
EPS (ttm) | -1.58 |
PE Ratio (ttm) | -2.75 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |